All In Biotech

Drug Trial Radar · NCT07547436

A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

A Randomized, Double-blinded, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Activity, Safety, and Tolerability of SAR445399 in Adult Participants With Non-Cystic Fibrosis Bronchiectasis (NCFB)

Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Suspended

Status

Suspended

Enrollment

70

Planned (sponsor's estimate)

Start

Jun 8, 2026

Primary completion

Oct 29, 2027

Study completion May 11, 2029

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Apr 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score at 24 weeks of treatment with SAR445399 compared with placebo in adult participants aged 18 to 80 years with non-cystic fibrosis bronchiectasis (NCFB).

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

  • SAR445399Biological

    Pharmaceutical form: solution for injection Route of administration: injection

  • PlaceboBiological

    Pharmaceutical form: solution for injection Route of administration: injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Week 24 in mucus plug score (MPS) derived from chest high-resolution computerized tomography (HRCT)Time frame: from baseline up to Week 24

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400008

    Phoenix, Arizona

  • Advanced Pulmonary Research Institute- Site Number : 8400001

    Loxahatchee Groves, Florida

  • Hull and Hull Medical Specialists- Site Number : 8400002

    Plantation, Florida

  • Clinical Research Associates of Central Pennsylvania- Site Number : 8400006

    DuBois, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.